首页> 外文期刊>Pharmacology & Pharmacy >Preparation and in Vitro Drug Release Evaluation of Once-Daily Metformin Hydrochloride Sustained-Release Tablets
【24h】

Preparation and in Vitro Drug Release Evaluation of Once-Daily Metformin Hydrochloride Sustained-Release Tablets

机译:每日一次盐酸二甲双胍缓释片的制备及体外释药评价

获取原文
       

摘要

The objective of this study was to develop once-daily metformin hydrochloride sustained-release tablets (MHSRT) and evaluate their in vitro release behavior. MHSRT were prepared by the film coating method. The in vitro drug release rate of MHSRT and the commercial tablets Fortamet? made in the United States of America in water was fitted with zero order kinetic equation, and Ritger-Peppas kinetic equation in 0.1 M HCl and pH 6.8-phosphate buffer, respectively. The similarity factor f2 values of MHSRT in three different dissolution medium were 82, 80 and 74, respectively in comparison with imported Fortamet?, which were all greater than 50. The results of storage-stability showed that MHSRT were stable for at least 6 months under stress condition (40℃ ± 2℃, RH 75% ± 5%). Therefore, in this study, MHSRT were successfully prepared using optimized formulation technologies that meet mass produce. The in vitro release behavior of MHSRT was almost similar to that of imported Fortamet?.
机译:这项研究的目的是开发每日一次的盐酸二甲双胍缓释片(MHSRT)并评估其体外释放行为。 MHSRT通过薄膜包衣法制备。 MHSRT和市售片剂Fortamet?的体外药物释放速率在美国制造的水中,分别在0.1 M HCl和pH 6.8磷酸盐缓冲液中拟合了零级动力学方程和Ritger-Peppas动力学方程。与三种均大于50的进口Fortamet?相比,三种不同溶出介质中MHSRT的相似因子f2值分别为82、80和74。存储稳定性结果表明MHSRT至少可稳定6个月在应力条件下(40℃±2℃,相对湿度75%±5%)。因此,在这项研究中,使用满足大规模生产的优化配方技术成功制备了MHSRT。 MHSRT的体外释放行为几乎与进口的Fortamet?类似。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号